Diagnostic and Biotech

Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL22843
  • 150 Pages
  • May 2017
  • Diagnostic and Biotech

Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimer’s disease, Parkinson disease, and other neurological disorders.

The global nerve repair and regeneration market was valued at $5,927 million in 2016, and is estimated to garner $13,938  million by 2023, registering a CAGR of 13.0% from 2017 to 2023. The major factors that enhance the market growth are increase in geriatric population, rise in incidence of neurological & epidemic disorders, and launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth.

The global nerve repair and regeneration market is segmented on the basis of surgery, product, and geography. Based on surgery, the market is classified into direct neuropathy, nerve grafting, neuromodulation surgery, and stem cell therapy. The neuromodulation surgeries segment contributed the highest share in 2016, owing to increase in patients suffering from neural disorders. Direct neuropathy is categorized into epineural repair, perineural repair, and group fascicular repair. Nerve grafting is subsegmented into autografts, allografts, and xenografts. Nerve modulation surgery is bifurcated into external and internal. By product, the market is divided into biomaterials and neuromodulation surgery devices. Neuromodulation surgery devices contributed the highest share in 2016, owing to the wide range of product offering for nerve repair. Biomaterial is classified into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Neuromodulation surgery devices is subsegmented into external and internal. External is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Internal is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North American market accounted for a significant share in 2016, owing to growth in number of patients suffering from neurological disorders.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global nerve repair and regeneration market and the current trends & future estimations to elucidate the imminent investment pockets.
  • The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
  • Extensive analysis of the market based on the surgeries and product elucidate the prevailing opportunities in these segments.
  • Comprehensive analysis of geographical regions is provided to determine the regional opportunities.
  • The key players operating in the market and their strategies are profiled to determine the competitive outlook of the market.

KEY MARKET SEGMENTS

By Surgery

  • Direct Neuropathy
    • Epineural Repair
    • Perineural Repair
    • Group Fascicular Repair
  • Nerve Grafting
    • Autografts
    • Allografts
    • Xenografts
  • Stem Cell Therapy
  • Neuromodulation Surgery
    • External Neuromodulation Surgery
    • Internal Neuromodulation Surgery

By Product

  • Biomaterials
    • Nerve Conduits
    • Nerve Protectors
    • Nerve Wraps
    • Nerve Connectors
  • Neuromodulation Surgery Devices
    • External Neuromodulation Surgery
      • Transcutaneous Electrical Nerve Stimulation
      • Transcranial Magnetic Stimulation
    • Internal Neuromodulation Surgery
      • Spinal Cord Stimulation
      • Deep Brain Stimulation
      • Sacral Nerve Stimulation
      • Vagus Nerve Stimulation
      • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

KEY PLAYERS PROFILED IN THE REPORT

  • AxoGen Inc. (U.S.)
  • Baxter International (U.S.)
  • Boston Scientific Incorporation (U.S.)
  • Cyberonics Inc. (U.S.)
  • Integra Lifesciences Corporation (U.S.)
  • Medtronic plc (U.S.)
  • Orthomed S.A.S. (France)
  • Polyganics B.V. (Netherlands)
  • St. Jude Medical (U.S.)
  • Stryker Corporation (U.S.)

OTHER PLAYERS IN THE VALUE CHAIN

(These players are not profiled in the report, but can be included on request)

  • Alafair Biosciences Inc.
  • Covidien Plc.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • NeuroMetrix, Inc.
  • Synapse Biomedical, Inc.
  • Convergent Technologies
  • Autonomic Technologies
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

2017 © Copyright Big Market Research

View Pricing >>